Picture of Wakamoto Pharmaceutical logo

4512 — Wakamoto Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Table: Wakamoto Pharm - 6-MTH parent results

Nov 7 (Reuters)- 
             Wakamoto Pharmaceutical Co Ltd 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2022        Sep 30, 2021     Mar 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             4.02                4.01             8.50     
                 (+0.3 pct)                           (+1.4 pct)  
  Operating      loss 85 mln        loss 172 mln        90 mln    
  Recurring      loss 27 mln        loss 153 mln        110 mln   
                                                      (+52.2 pct) 
  Net            loss 21 mln           111 mln          150 mln   
                                                      (-37.1 pct) 
  EPS           loss 0.62 yen         3.22 yen         4.32 yen   
  Ann Div                                NIL                      
  -Q2 div            NIL                 NIL                      
  -Q4 div                                NIL                      
  
  NOTE - Wakamoto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T

Recent news on Wakamoto Pharmaceutical

See all news